Stockscreener 앱 받기
28.22
1.18%
0.33
시간 외 거래:
28.80
0.58
+2.06%
전일 마감가:
$27.89
열려 있는:
$28.26
하루 거래량:
2.17M
Relative Volume:
1.65
시가총액:
$4.17B
수익:
$15.06M
순이익/손실:
$-242.05M
주가수익비율:
-15.50
EPS:
-1.8204
순현금흐름:
$-181.28M
1주 성능:
-1.71%
1개월 성능:
+4.63%
6개월 성능:
+22.64%
1년 성능:
+78.49%
1일 변동 폭
$27.86
$29.47
1주일 범위
$25.17
$29.47
52주 변동 폭
$9.60
$30.58
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
명칭
Centessa Pharmaceuticals Plc Adr
전화
44 7391 789784
주소
3RD FLOOR, ALTRINCHAM, CHESHIRE
Compare CNTA vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
28.22 | 4.12B | 15.06M | -242.05M | -181.28M | -1.8204 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-24 | 개시 | Wolfe Research | Outperform |
| 2025-12-10 | 재개 | Oppenheimer | Outperform |
| 2025-10-28 | 개시 | Stephens | Overweight |
| 2025-09-03 | 개시 | Wells Fargo | Overweight |
| 2025-08-29 | 재개 | Oppenheimer | Outperform |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-05-28 | 개시 | Needham | Buy |
| 2025-05-08 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-31 | 개시 | Piper Sandler | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
| 2024-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | 개시 | B. Riley Securities | Buy |
| 2024-07-18 | 개시 | Oppenheimer | Outperform |
| 2023-11-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-10-26 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | 개시 | Evercore ISI | Outperform |
| 2023-06-12 | 개시 | Guggenheim | Buy |
| 2023-03-17 | 개시 | SVB Securities | Outperform |
| 2022-08-12 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-02-11 | 개시 | Goldman | Neutral |
모두보기
Centessa Pharmaceuticals Plc Adr 주식(CNTA)의 최신 뉴스
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Karen Anderson Sells 64,768 Shares - MarketBeat
Karen Anderson Sells 10,043 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock - MarketBeat
Karen M. Anderson sells ADRs; CNTA (NASDAQ: CNTA) Form 144 notice - Stock Titan
Cinctive Capital Management LP Purchases New Stake in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
[144] Centessa Pharmaceuticals plc SEC Filing - Stock Titan
First Light Asset Management LLC Sells 657,595 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Foresite Capital Management VI LLC Buys 60,640 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Holdings Cut by Commodore Capital LP - MarketBeat
Centessa Pharmaceuticals CEO Touts ORX750 as Best-in-Class as Registration Studies Nearing Start - Yahoo Finance
Avoro Capital Advisors LLC Buys 5,808,080 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Gregory Weinhoff Sells 73,196 Shares of Centessa Pharmaceuticals (NASDAQ:CNTA) Stock - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Karen Anderson Sells 120,029 Shares - MarketBeat
CNTA (NASDAQ: CNTA) insider files Form 144 to sell 120,029 ADRs valued $3.10M - Stock Titan
Capital World Investors Has $16.61 Million Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by American Century Companies Inc. - Defense World
American Century Companies Inc. Has $27.08 Million Stock Position in BJ’s Restaurants, Inc. $BJRI - Defense World
Centessa Pharmaceuticals Teases ORX750 Phase II Update, Registrational Study Start at Conference - Yahoo Finance
Blue Owl Capital Holdings LP Reduces Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Royce & Associates LP Acquires New Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
CNTA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TD Asset Management Inc Trims Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition - AOL.com
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline - The Motley Fool
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Sold by Aberdeen Group plc - Defense World
Norsk Hydro ASA (OTCMKTS:NHYDY) Cut to “Strong Sell” at Kepler Capital Markets - Defense World
Eagle Health Investments LP Makes New Investment in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA) - Finviz
Caprock Group LLC Buys New Stake in iShares Bitcoin Trust ETF $IBIT - Defense World
Centessa Pharmaceuticals CEO Teases “Transformational” 2026 as ORX750 Nears Registrational Trials - Yahoo Finance
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap DownWhat's Next? - MarketBeat
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 1,010 Shares of Stock - MarketBeat
WCM Investment Management LLC Increases Stock Position in Novo Nordisk A/S $NVO - Defense World
Best Infrastructure Stocks To Watch Now – January 31st - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Federated Hermes Inc. Purchases Shares of 1,749,650 Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Strong Trading VolumeTime to Buy? - MarketBeat
Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Truist Hikes Centessa (CNTA) PT to $33 While Maintaining Consistent 2026 Thesis - Finviz
A Look At Centessa Pharmaceuticals (CNTA) Valuation After New Analyst Focus On Orexin Pipeline Expansion - Sahm
Needham Hikes Centessa (CNTA) PT to $38 on High Potential for ORX-750 Trial Success and M&A Appeal - Finviz
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Armistice Capital LLC Lowers Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
oracle, visa among market cap stock movers on thursday By Investing.com - Investing.com UK
oracle, visa among market cap stock movers on thursday - Investing.com India
Russell Investments Group Ltd. Has $1.85 Million Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals Plc Adr (CNTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):